Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration.
Nguyen QD, Shah SM, Hafiz G, Quinlan E, Sung J, Chu K, Cedarbaum JM, Campochiaro PA; CLEAR-AMD 1 Study Group. Nguyen QD, et al. Among authors: hafiz g. Ophthalmology. 2006 Sep;113(9):1522.e1-1522.e14. doi: 10.1016/j.ophtha.2006.05.055. Epub 2006 Jul 28. Ophthalmology. 2006. PMID: 16876249 Clinical Trial.
Monitoring ocular drug therapy by analysis of aqueous samples.
Campochiaro PA, Choy DF, Do DV, Hafiz G, Shah SM, Nguyen QD, Rubio R, Arron JR. Campochiaro PA, et al. Among authors: hafiz g. Ophthalmology. 2009 Nov;116(11):2158-64. doi: 10.1016/j.ophtha.2009.04.038. Epub 2009 Aug 22. Ophthalmology. 2009. PMID: 19700195
Topical mecamylamine for diabetic macular edema.
Campochiaro PA, Shah SM, Hafiz G, Heier JS, Lit ES, Zimmer-Galler I, Channa R, Nguyen QD, Syed B, Do DV, Lu L, Monk J, Cooke JP, Kengatharan MK, Hsu HH. Campochiaro PA, et al. Among authors: hafiz g. Am J Ophthalmol. 2010 May;149(5):839-51.e1. doi: 10.1016/j.ajo.2009.12.005. Epub 2010 Feb 26. Am J Ophthalmol. 2010. PMID: 20189159 Free PMC article. Clinical Trial.
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
Campochiaro PA, Hafiz G, Shah SM, Bloom S, Brown DM, Busquets M, Ciulla T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane F; Famous Study Group. Campochiaro PA, et al. Among authors: hafiz g. Ophthalmology. 2010 Jul;117(7):1393-9.e3. doi: 10.1016/j.ophtha.2009.11.024. Epub 2010 Mar 3. Ophthalmology. 2010. PMID: 20202684 Clinical Trial.
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphate.
Ibrahim MA, Do DV, Sepah YJ, Shah SM, Van Anden E, Hafiz G, Donahue JK, Rivers R, Balkissoon J, Handa JT, Campochiaro PA, Nguyen QD. Ibrahim MA, et al. Among authors: hafiz g. BMC Pharmacol Toxicol. 2013 Jan 14;14:7. doi: 10.1186/2050-6511-14-7. BMC Pharmacol Toxicol. 2013. PMID: 23316779 Free PMC article. Clinical Trial.
71 results